Literature DB >> 3289349

Systemic hypertension in diabetes mellitus.

J V Felicetta1, J R Sowers.   

Abstract

Hypertension occurs more frequently in diabetics and markedly exacerbates the vascular morbidity and mortality resulting from this metabolic disorder. However, the etiology of hypertension in diabetics remains poorly understood. Like aging persons, diabetics have increased systemic resistance and a probable reduction in baroreceptor sensitivity. They also have an expanded total body sodium pool and a tendency to lower levels of plasma renin activity. Some of these factors suggest that a subtle calcium deficiency could also be of etiologic importance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289349     DOI: 10.1016/0002-9149(88)91103-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-09

Review 4.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

Review 5.  Major adverse cardiovascular event reduction with GLP-1 and SGLT2 agents: evidence and clinical potential.

Authors:  Michael E Røder
Journal:  Ther Adv Chronic Dis       Date:  2017-11-09       Impact factor: 5.091

Review 6.  The Benefit of Sodium-Glucose Co-Transporter Inhibition in Heart Failure: The Role of the Kidney.

Authors:  Edoardo Gronda; Emilio Vanoli; Massimo Iacoviello; Pasquale Caldarola; Domenico Gabrielli; Luigi Tavazzi
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.